Alberta

Alberta is rapidly emerging as a global life sciences hub, distinguished by a robust biotechnology and pharmaceutical infrastructure and a collaborative healthcare innovation ecosystem.

The province is internationally recognized for its leadership in virology, diabetes research and oncology, anchored by world-class academic institutions like the University of Alberta and the University of Calgary.

Strategically positioned as a leader in biomanufacturing, Alberta’s Applied Pharmaceutical Innovation (API) and the Critical Medicines Production Centre (CMPC) provide essential CDMO and CRO services to accelerate drug development.

The region’s medical device sector thrives on a unique "living lab" environment provided by Alberta Health Services, the largest integrated healthcare system in Canada, which streamlines clinical trials and technology adoption.

Propelled by significant venture capital investment and government support through Alberta Innovates, the ecosystem fosters a high concentration of life sciences startups specializing in digital health, diagnostics and precision medicine.

With a highly skilled talent pool and a competitive R&D tax credit framework, Alberta offers a cost-effective, de-risked pathway for international firms looking to scale within the North American market.

This dynamic environment ensures that Alberta remains at the forefront of delivering life-saving health technology solutions to a global audience.